Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome

Guillermo Garcia-Manero, Francesco Paolo Tambaro, Nebiyou B. Bekele, Hui Yang, Farhad Ravandi, Elias Jabbour, Gautam Borthakur, Tapan M. Kadia, Marina Y. Konopleva, Stefan Faderl, Jorge E. Cortes, Mark Brandt, Yumin Hu, Deborah McCue, Willie Mae Newsome, Sherry R. Pierce, Marcos De Lima, Hagop M. Kantarjian

Research output: Contribution to journal › Article › peer-review

145 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences